Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc/ US92532F1003 /
VX1/D
|
14.11.2024 16:30:07
|
Изменение
-
|
Объем сделки |
Бид17:30:00 |
Предложение17:30:00 |
Рыночная капитализация |
Дивидендная доходность |
Коэффициент Цена/Доход |
|
461.30EUR
|
-
|
66
Оборот: 26,080.60 |
-Величина цены спроса: - |
-Величина цены предложения: - |
113.92 млрдEUR |
- |
- |
Описание деятельности
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to its clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For five years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences.
Правление & Наблюдательный совет
| Исполнительный директор |
| Reshma Kewalramani, M.D. |
| Правление |
| Charles F. Wagner, Jr., David Altshuler, Stuart A. Arbuckle, Jonathan Biller, Carmen Bozic, Amit K. Sachdev, Bastiano Sanna, Nia Tatsis, E. Morrey Atkinson, Ph.D. |
| Наблюдательный совет |
| Dr. Jeffrey Leiden, Bruce I. Sachs, Diana McKenzie, Dr. Alan Garber, Dr. Sangeeta N. Bhatia, Lloyd Carney, Reshma Kewalramani, Terrence C. Kearney, Suketu (Suky) Upadhyay |
Данные компании
| Имя: |
Vertex Pharmaceuticals Inc. |
| Адрес: |
50 Northern Avenue,Boston, Massachusetts 02210, USA |
| Телефон: |
+1-617-961-7163 |
| Факс: |
- |
| E-mail: |
Investorinfo@VRTX.com
|
| Интернет: |
www.vrtx.com/ |
| Индустрия: |
Healthcare |
| Сектор: |
Pharmaceutical Industry |
| Подсектор: |
Pharmaceuticals |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
82.70% |
| Дата IPO: |
24.07.1991 |
Связи с инвесторами
| Имя: |
Susie Lisa |
| IR телефон: |
+1-617-341-6108 |
| IR-факс: |
- |
| IR e-mail: |
investorinfo@vrtx.com
|
Основные акционеры
| Другие |
|
53.31% |
| Vanguard Group |
|
8.63% |
| BlackRock Inc. |
|
8.48% |
| Capital World Investors |
|
8.45% |
| FMR LLC. |
|
5.03% |
| State Street Corporation |
|
4.68% |
| ALLIANCEBERNSTEIN L P |
|
2.73% |
| PRICE T ROWE ASSOCIATES INC MD |
|
2.28% |
| GEODE CAPITAL MANAGEMENT LLC |
|
2.20% |
| Другие |
|
4.21% |
